CLB logo

Core Laboratories NV (CLB) Accounts Payable

Annual Accounts Payable

$33.51 M
-$12.34 M-26.92%

31 December 2023

CLB Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$33.63 M
-$3.24 M-8.78%

30 September 2024

CLB Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLB Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-26.9%-1.4%
3 y3 years+45.5%-4.0%
5 y5 years-18.6%-20.3%

CLB Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-26.9%+45.5%-26.6%+13.1%
5 y5 years-26.9%+45.5%-26.6%+47.5%
alltimeall time-41.9%+520.5%-45.2%+1020.9%

Core Laboratories NV Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$33.63 M(-8.8%)
June 2024
-
$36.86 M(+13.5%)
Mar 2024
-
$32.49 M(-3.0%)
Dec 2023
$33.51 M(-26.9%)
$33.51 M(-1.7%)
Sept 2023
-
$34.10 M(-12.9%)
June 2023
-
$39.15 M(+2.0%)
Mar 2023
-
$38.37 M(-16.3%)
Dec 2022
$45.85 M(+54.2%)
$45.85 M(+33.5%)
Sept 2022
-
$34.34 M(-4.9%)
June 2022
-
$36.11 M(+4.9%)
Mar 2022
-
$34.41 M(+15.7%)
Dec 2021
$29.73 M(+29.1%)
$29.73 M(-15.1%)
Sept 2021
-
$35.02 M(+15.2%)
June 2021
-
$30.38 M(+19.1%)
Mar 2021
-
$25.50 M(+10.7%)
Dec 2020
$23.03 M(-35.3%)
$23.03 M(+1.0%)
Sept 2020
-
$22.81 M(-3.7%)
June 2020
-
$23.69 M(-36.1%)
Mar 2020
-
$37.05 M(+4.1%)
Dec 2019
$35.61 M(-13.5%)
$35.61 M(-15.6%)
Sept 2019
-
$42.19 M(+0.5%)
June 2019
-
$41.99 M(-5.6%)
Mar 2019
-
$44.47 M(+8.0%)
Dec 2018
$41.16 M(-1.3%)
$41.16 M(+0.3%)
Sept 2018
-
$41.01 M(-9.4%)
June 2018
-
$45.28 M(-0.6%)
Mar 2018
-
$45.54 M(+9.2%)
Dec 2017
$41.70 M(+23.7%)
$41.70 M(+19.5%)
Sept 2017
-
$34.90 M(-16.1%)
June 2017
-
$41.61 M(+14.1%)
Mar 2017
-
$36.48 M(+8.2%)
Dec 2016
$33.72 M(+0.7%)
$33.72 M(+4.7%)
Sept 2016
-
$32.20 M(+9.5%)
June 2016
-
$29.40 M(-15.4%)
Mar 2016
-
$34.75 M(+3.8%)
Dec 2015
$33.47 M(-28.9%)
$33.47 M(-17.4%)
Sept 2015
-
$40.54 M(-4.2%)
June 2015
-
$42.32 M(-17.0%)
Mar 2015
-
$51.00 M(+8.3%)
Dec 2014
$47.08 M(-7.4%)
$47.08 M(-5.2%)
Sept 2014
-
$49.65 M(-3.2%)
June 2014
-
$51.29 M(-4.5%)
Mar 2014
-
$53.72 M(+5.7%)
Dec 2013
$50.82 M(-7.9%)
$50.82 M(-5.7%)
Sept 2013
-
$53.90 M(-3.6%)
June 2013
-
$55.93 M(+3.4%)
Mar 2013
-
$54.08 M(-2.0%)
Dec 2012
$55.17 M(-4.3%)
$55.17 M(+20.5%)
Sept 2012
-
$45.78 M(-10.7%)
June 2012
-
$51.28 M(+6.4%)
Mar 2012
-
$48.19 M(-16.4%)
Dec 2011
$57.64 M(+28.9%)
$57.64 M(+23.2%)
Sept 2011
-
$46.78 M(-23.7%)
June 2011
-
$61.33 M(+25.8%)
Mar 2011
-
$48.75 M(+9.0%)
Dec 2010
$44.71 M
$44.71 M(+16.1%)
Sept 2010
-
$38.51 M(-2.6%)
June 2010
-
$39.53 M(+8.2%)
DateAnnualQuarterly
Mar 2010
-
$36.53 M(+10.7%)
Dec 2009
$33.01 M(-20.6%)
$33.01 M(+18.0%)
Sept 2009
-
$27.98 M(+4.3%)
June 2009
-
$26.84 M(-1.4%)
Mar 2009
-
$27.22 M(-34.6%)
Dec 2008
$41.59 M(+4.3%)
$41.59 M(+6.3%)
Sept 2008
-
$39.11 M(+1.1%)
June 2008
-
$38.68 M(+8.4%)
Mar 2008
-
$35.69 M(-10.5%)
Dec 2007
$39.86 M(+6.4%)
$39.86 M(-12.6%)
Sept 2007
-
$45.60 M(-5.5%)
June 2007
-
$48.25 M(+44.0%)
Mar 2007
-
$33.51 M(-10.5%)
Dec 2006
$37.46 M(+15.1%)
$37.46 M(+21.7%)
Sept 2006
-
$30.77 M(-8.7%)
June 2006
-
$33.70 M(+11.8%)
Mar 2006
-
$30.15 M(-7.4%)
Dec 2005
$32.56 M(+13.7%)
$32.56 M(+21.4%)
Sept 2005
-
$26.81 M(-3.7%)
June 2005
-
$27.85 M(-4.0%)
Mar 2005
-
$29.00 M(+1.3%)
Dec 2004
$28.63 M(+12.3%)
$28.63 M(+11.9%)
Sept 2004
-
$25.59 M(+6.1%)
June 2004
-
$24.12 M(+10.2%)
Mar 2004
-
$21.89 M(-14.1%)
Dec 2003
$25.49 M(+0.3%)
$25.49 M(+3.3%)
Sept 2003
-
$24.67 M(+7.0%)
June 2003
-
$23.06 M(-8.3%)
Mar 2003
-
$25.15 M(-1.0%)
Dec 2002
$25.41 M(+28.8%)
$25.41 M(+63.3%)
Sept 2002
-
$15.56 M(+1.5%)
June 2002
-
$15.34 M(-3.8%)
Mar 2002
-
$15.95 M(-19.1%)
Dec 2001
$19.72 M(-23.9%)
$19.72 M(+14.2%)
Sept 2001
-
$17.27 M(-15.8%)
June 2001
-
$20.53 M(+8.5%)
Mar 2001
-
$18.92 M(-27.0%)
Dec 2000
$25.93 M(+31.1%)
$25.93 M(+28.8%)
Sept 2000
-
$20.14 M(-3.8%)
June 2000
-
$20.94 M(+12.6%)
Mar 2000
-
$18.61 M(-5.9%)
Dec 1999
$19.77 M(-0.6%)
$19.77 M(+25.2%)
Sept 1999
-
$15.80 M(+8.2%)
June 1999
-
$14.60 M(-12.6%)
Mar 1999
-
$16.70 M(-16.1%)
Dec 1998
$19.90 M(-14.2%)
$19.90 M(+43.2%)
Sept 1998
-
$13.90 M(-48.1%)
June 1998
-
$26.80 M(+104.6%)
Mar 1998
-
$13.10 M(-43.5%)
Dec 1997
$23.20 M(+293.2%)
$23.20 M(+79.8%)
Sept 1997
-
$12.90 M(+4.0%)
June 1997
-
$12.40 M(+63.2%)
Mar 1997
-
$7.60 M(+28.8%)
Dec 1996
$5.90 M(+9.3%)
$5.90 M(+78.8%)
Sept 1996
-
$3.30 M(-17.5%)
June 1996
-
$4.00 M(+33.3%)
Mar 1996
-
$3.00 M(-44.4%)
Dec 1995
$5.40 M
$5.40 M(+14.9%)
Sept 1995
-
$4.70 M

FAQ

  • What is Core Laboratories NV annual accounts payable?
  • What is the all time high annual accounts payable for Core Laboratories NV?
  • What is Core Laboratories NV annual accounts payable year-on-year change?
  • What is Core Laboratories NV quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Core Laboratories NV?
  • What is Core Laboratories NV quarterly accounts payable year-on-year change?

What is Core Laboratories NV annual accounts payable?

The current annual accounts payable of CLB is $33.51 M

What is the all time high annual accounts payable for Core Laboratories NV?

Core Laboratories NV all-time high annual accounts payable is $57.64 M

What is Core Laboratories NV annual accounts payable year-on-year change?

Over the past year, CLB annual accounts payable has changed by -$12.34 M (-26.92%)

What is Core Laboratories NV quarterly accounts payable?

The current quarterly accounts payable of CLB is $33.63 M

What is the all time high quarterly accounts payable for Core Laboratories NV?

Core Laboratories NV all-time high quarterly accounts payable is $61.33 M

What is Core Laboratories NV quarterly accounts payable year-on-year change?

Over the past year, CLB quarterly accounts payable has changed by -$470.00 K (-1.38%)